Skip to main content
Premium Trial:

Request an Annual Quote

Biotage Reports Lackluster Sales for a Disappointing Third Quarter

NEW YORK, Oct. 21 (GenomeWeb News) - Biotage today reported sales of 84.5 million Swedish krona ($11.7 million) for the third-quarter, the company said today in a statement.


Sales fell below company expectations because software for its upcoming purification instrument took longer to complete than planned, and deliveries were delayed, said the company. Sales were slow in the third quarter as well, but are expected to pick up in both of the company's business areas during the fourth quarter, the company added.


Restructurings accounted for 5 million krona of total operating costs of 73.3 million krona, but the restructurings, which reduced the number of employees by 14, will save the company 15 million krona annually, Biotage said.


Biotage, which  changed its name from Pyrosequencing one year ago, did not report expenses, earnings, or assets.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.